The disconnect between great news and a compressed IPIX

New Post Public Reply Private Reply Replies (2) Message Board
Mo Mo #63656
1,297
The disconnect between great news and a compressed IPIX share price (SP) is obvious to anyone who has been paying attention. I spelled this out in detail in post #63656 that is a sticky post above.

As I have mentioned numerous times the advancement of the science is the ONLY thing that matters at this point IMO. IPIX investors are part owners of what very well could be THE BEST AND MOST EFFECTIVE TREATMENT FOR COVID-19. Some will call this “drinking the Kool-Aid” which could be the line of thinking of a short term stock trader, an impatient investor or possibly a paid poster trying to divert great news of IPIX science advancement by highlighting the criminally controlled SP.

Many Longs on this board have tried to educate the masses on the how, what and who in regards to the criminal manipulation of IPIX’s SP. Naked Short Selling is one of the tools that the criminals use to maintain control in the short term as they continue to compress SP. However, if the criminals target a company that has “the goods” that successfully make it to market, the criminals are screwed. Again, anyone who has been paying attention knows that as milestones are met that the criminal control over IPIX SP will loosen. In the short term SP DOES NOT MATTER. IPIX SP will sharply go up as the following key milestones are met:

Non-dilutive funding in the form of government grants and or Pharmaceutical partnerships.

Human lung testing results.

Successful COVID-19 specific human trial completion.

Brilacidin NDA approval for COVID-19 which will in turn greatly accelerate B-OM and B-IBD Oral approvals creating enormous revenue and royalties.

Eventual IPIX Up-listing off criminally controlled OTX.

Advancement of Kevetrin science.

Unwinding of criminal NSS covering which will have a slingshot upward effect on SP.

Eventual sale of IPIX a few years down the road.

Each of the above milestones will drive IPIX SP up in multiple dollar chunks REGARDLESS of what the criminals/NR do. IPIX is on track for all of the above to take place. The criminals need actual shares to cover their naked position and will attempt to persuade investors to start their exit strategies in the beginning of the above milestones. Selling into these initial milestones will be a long term mistake IMO. Each milestone above will add multiple dollars to IPIX’s share price and Brilacidin will save many thousands of lives.




Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Shanghai's Arts Carnival Fuses Tech and Culture

Updated Category News Views 2

Shanghai Heralds New Era in Arts with Carnival Coming in hot, Shanghai's ready to shake up the city's cultural scene with the 2026 International Audio-Visual Arts Carnival. It's happening in Jing'an District from September 24 to October 18, promising an experience that fuses travel, technology, and art. Just about anyone can catch a break from their daily grind and dive...

Continue Reading
Fast Guard Elevates Nationwide Fire Watch Mission

Updated Category News Views 2

Fast Guard: The Unseen Shield Behind Property Safety Hollywood, Florida might be best known for its sun-kissed beaches, but in the world of fire safety, it’s the nerve center for emergency fire watch response. Fast Guard Service isn’t just any run-of-the-mill security outfit; it’s rapidly becoming the unsung hero of property managers across the nation. When those...

Continue Reading
Quay Dominates 2026 Sunglasses Review for Variety

Updated Category News Views 4

Sunglasses Designed for Every Face Type When it comes to picking the right pair of shades, face shape is only part of the equation. Expert Consumers just dropped their 2026 verdict, spotlighting Quay as the go-to brand for those wider faces, tricky nose bridges, and the noggins that run a tad larger than average. Forget what you heard about one-size-fits-all. This...

Continue Reading
Qatar Foundation Spurs Sport-Driven Empowerment Moves

Updated Category News Views 1

Here we go, diving into the serious talk of the moment: sports pushing boundaries to uplift society's underdogs. Envision yourself in the halls of Wilton Park, where the thinkers, the dreamers, and the doers convened in the name of change. Qatar Foundation ain't just sitting pretty; they're championing the cause to harness sport for impactful social threads across the...

Continue Reading
PayPal Under Investigation: Legal Battles Intensify

Updated Category News Views 3

A Bumpy Ride for PayPal's Investors Back in 2025, PayPal was beaming about new growth strategies, filling the air with grandiose promises. Fast forward to February 2026, and the script had flipped entirely. Earnings came in nasty and disappointing, particularly in the Branded Checkout front. Adding to the chaos was their CEO unceremoniously taking the high road out the...

Continue Reading
Insta360 Expands with Times Square Flagship Store

Updated Category News Views 5

Insta360 Times Square Opening Marks Bold Expansion I dropped by Times Square today, and what do I see? Insta360 planting its flag right in the heart of New York City. Now, this isn't your run-of-the-mill grand opening—it’s the first flagship store outside of Asia, and it screams of big ambitions. Nestled at 1515 Broadway, the store is smack in the middle of one of the...

Continue Reading
Papa John's Faces Class Action Over Misleading Info

Updated Category News Views 2

Trouble Brewing for Papa John's Investors Rolling the dice in the stock market sometimes feels like playing the lottery, doesn't it? This time around, it's Papa John's (NASDAQ: PZZA) serving up a slice of turmoil for its investors. The pizza chain's got itself tangled in a class-action lawsuit, and it's the shareholders who're left with a bitter taste. Investors Cry Foul...

Continue Reading
Beta Bionics Lawsuit Deadline: Investors Face November 3 Cut-off

Updated Category News Views 5

Looming Deadline for Beta Bionics Investors Time's ticking fast for those holding onto Beta Bionics (BBNX) stock who might've been caught in a web of undisclosed risks and regulatory misses. Investors feeling the pinch from this fiasco have till November 3, 2026, to throw their hat in the ring as lead plaintiffs in the class action lawsuit out of California. The...

Continue Reading
GAC's Cambodia Plant: A Strategic Manufacturing Shift

Updated Category News Views 3

Setting the Stage for New Industrial Growth On September 17, a milestone was etched in the sands of Cambodia when the GAC Cambodia KD Plant officially flipped the switch. This ain't just another factory throwing doors open; it's a fresh chapter in regional manufacturing power plays. We had some big hitters in attendance, like Cambodian Prime Minister Hun Manet, showing...

Continue Reading
Flying Car Regulatory Sandbox Begins in UAE

Updated Category News Views 5

Pioneering Flying Cars in the Desert In a move that seems right out of a science fiction screenplay, ARIDGE—the bigwig of flying cars from Asia—has taken a giant leap. They’ve cozied up with the UAE, locking arms to cook up the world's first regulatory sandbox for personal flying cars. Now, don’t laugh—sandbox isn't just for toddlers. It’s the playground where...

Continue Reading

Top 5 Most Recently Viewed Articles

Velo & Tomorrowland Bring Music Magic to Ibiza

Updated Category News Views 18

A New Chapter for Dance Music Fans When it comes to chasing euphoria on a dance floor, Velo and Tomorrowland are pushing the envelope. They're launching 'Echoes of Tomorrowland,' a global web of live events and synchronised livestreams targeting dance music fans worldwide. The aim? To airlift the magic of Tomorrowland straight to your doorstep, whether you’re in Ibiza...

Continue Reading
Addex and Indivior Advance GABAB PAM Candidates

Updated Category News Views 173

Addex and Indivior Progress GABAB Positive Allosteric Modulators Ad Hoc Announcement Pursuant to Art. 53 LR Addex Therapeutics (SIX/NASDAQ: ADXN), a clinical-stage biopharmaceutical firm dedicated to developing innovative small molecule allosteric modulators for neurological disorders, has partnered with Indivior PLC (NASDAQ/LSE: INDV) to announce the selection of...

Continue Reading
Nykredit Reports Record Performance in 2024 Financial Results

Updated Category News Views 213

Nykredit Delivers Strong Annual Report for 2024 Nykredit Realkredit A/S has unveiled its Annual Reports for 2024, showcasing exceptional performance yet again. With a commitment to enhancing financial services and a focus on customer benefits, Nykredit continues to set new standards in the banking sector. Impressive Growth and Strategic Outlook Michael Rasmussen, the...

Continue Reading
AppLovin Corp Sees Stock Recovery Amid SEC Investigations

Updated Category News Views 220

AppLovin's Stock Performance on Tuesday AppLovin Corp (NASDAQ: APP) experienced a notable rebound on a recent Tuesday. After facing a significant decline during the previous trading session, the company's shares displayed resilience by moving higher as the market opened. Understanding the Recent Market Movements On Monday, AppLovin shares fell by approximately 14%. This...

Continue Reading
Southern First Bancshares Delivers Impressive Q3 Results

Updated Category News Views 37

Overview of Third Quarter Results Southern First Bancshares, Inc. (NASDAQ: SFST), the parent company of Southern First Bank, has recently reported its financial outcomes for the third quarter of the fiscal year. This period reflects the company's consistent focus on growing a high-quality balance sheet and enhancing its financial position. The results highlight the...

Continue Reading